Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


A Randomized, Double-Blind Study of Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05242029

Organisation Name: Johns Hopkins University

Overal Status: Not yet recruiting

Start Date: October 2022

Last Update: August 24, 2022

Lead Sponsor: Johns Hopkins University

Brief Summary: This study will investigate whether psilocybin administered under supportive conditions can reduce illicit opioid use and improve quality of life in individuals with Opioid Use Disorder (OUD) in Methadone Maintenance Treatment (MMT) who are concurrently using other opioids illicitly.

Conditions:
  • Opioid Use Disorder


Total execution time in seconds: 1.9849169254303